Delivery Order SPE2DB22D1041-SPE2DB25FUCL7
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Keppra (levetiracetam) 750 mg tablets in a quantity of 120 units. This competitive award, valued at $9,337.76, carries a firm fixed price and is scheduled for completion by September 29, 2025. The contract is not set-aside and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $14,293.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Keppra 1,000 mg tablets (60-count units), with a completion date of April 23, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $15,188.17 to AmerisourceBergen Drug Corp for the supply of Keppra 500 mg tablets (120-count units). This firm fixed-price delivery order, awarded on June 27, 2025, with an ultimate completion date of June 30, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,469.62 to AmerisourceBergen Drug Corp for the supply of Keppra 1,000 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 4, 2025, with performance to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating open competition among qualified pharmaceutical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEPPRA 500 mg tablets. The contract has a ceiling value of $10,453.67 and a performance period through June 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for providing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,076.37 on August 14, 2025, for the supply of Keppra 750 mg tablets (120-count units). The contract is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and was funded through the Defense Logistics Agency's Medical Supply Chain. No set-aside designation was applied to this competitively awarded contract,...
- This is a $4,504.98 firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEPPRA 500 MG TABLET 120S, a neurological medication, with a period of performance through June 17, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,077.29 firm fixed-price delivery order is for 4,566,963,297 units of the drug KEPPRA 500 MG TABLET, with a performance period through January 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,965.54, is for the supply of KEPPRA 500 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order, has no set-aside designation, and has an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Keppra 1,000 mg tablets. The contract has a ceiling value of $12,577.01 and a completion date of April 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCL7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Keppra 500 mg tablets (120-count units) valued at $9,435.40. This firm fixed-price delivery order, which is due for completion by September 26, 2025, represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of pharmaceutical and medical supply deliveries across multiple therapeutic domains. This delivery order falls within AmerisourceBergen's comprehensive $999.999 billion IDC with DLA Troop Support Medical (contract SPE2DX), which runs through December 2026 and enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs. The Keppra order specifically supports the Defense Health Agency and other federal healthcare systems' requirements for neurological medications. AmerisourceBergen's demonstrated capability to meet federal procurement standards through competitive awards—evidenced by consistent delivery order performance across various therapeutic categories—positions the company as a key provider within DLA's pharmaceutical supply chain serving the Department of Defense and related federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/25/25 |